Abstract
The sympathetic nervous system plays an important role in the multifactorial pathogenesis of hypertensive disease. The objective of this chapter is to describe the role of adrenergic activation in the development of hypertension and to understand the neuroendocrine mechanisms contributing to the pathogenesis of hypertension.
The first part will describe methods used to investigate the adrenergic tone. In the second part, the physiological effects of sympathetic activation will be covered, as well as the pressor mechanisms of sympathetic activity that might result in hypertension. The third part will take into account the evidences indicating increased sympathetic activity in the different stages of the hypertensive disease. The last part will describe the mechanisms leading to sympathetic activation and new mechanisms hypothesized by data collected in recent years.
Keywords
- Muscle Sympathetic Nerve Activity
- Dihydroxyphenylglycol (DHPG)
- Baroreceptor Function
- Measure Catecholamine Levels
- Microneurography
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
References
Esler MD (2011) The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension. Exp Physiol 96:611–622
Grassi G, Mark A, Esler M (2015) The sympathetic nervous system alterations in human hypertension. Circ Res 116:976–990
Hjemdahl P (1993) Plasma catecholamines: analytical challenges and physiological limitations. Clin Endocrinol Metab 7:307–353
Esler M, Jennings G, Korner P et al (1988) The assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11:3–20
Schlaich MP, Lambert E, Kaye DM et al (2004) Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 43:169–175
Bertinieri G, di Rienzo M, Cavallazzi A et al (1985) A new approach to analysis of the arterial baroreflex. J Hypertens 3:S79–S81
Mancia G, Grassi G (1995) Baroreceptor control of the circulation in man. An update. Clin Exp Hypertens 17:387–397
Halliwill JR (2000) Segregated signal averaging of sympathetic baroreflex responses in humans. J Appl Physiol 88:767–773
Charkoudian N, Martin EA, Dinenno FA et al (2004) Influence of increased central venous pressure on baroreflex control of sympathetic activity in humans. Am J Physiol Heart Circ Physiol 287:H1658–H166210
Pagani M, Lombardi F, Guzzetti S et al (1986) Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 59:178–193
Task Force of the European Society of Cardiology and The North American Society of Pacing and Electrophysiology (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17:354–381
Grassi G, Esler MD (1999) How to assess sympathetic activity in humans. J Hypertens 17:719–734
Delius W, Hagbarth KE, Hogell A, Wallin BG (1972) General characteristics of sympathetic activity in human muscle nerves. Acta Physiol Scand 84:65–81
Grassi G, Bolla G, Seravalle G et al (1997) Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci 92:285–289
Eckberg DL, Wallin BG, Fagius J et al (1989) Prospective study of symptoms after human microneurography. Acta Physiol Scand 137:567–569
Grassi G, Seravalle G, Dell’Oro R et al (2001) Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity. Hypertension 38:1316–1320
Guyenet PG (2006) The sympathetic control of blood pressure. Nat Rev Neurosci 7:335–346
Lohmeier TE, Dwyer TM, Irwin ED et al (2007) Prolonged activation of baroreflex abolishes obesity-induced hypertension. Hypertension 49:1307–1314
Jose PA, Eisner GM, Felder RA (2002) Role of dopamine receptors in the kidney in the regulation of blood pressure. Curr Opin Nephrol Hypertens 11:87–92
Kopp UC, DiBona GF (1993) Neural regulation of renin secretion. Semin Nephrol 13:543–551
Johns EJ, Kopp UC, DiBona GF (2011) Neural control of renal function. Compr Physiol 1:731–767
Iliescu R, Irwin ED, Georgakopoulos D, Lohmeier TE (2012) Renal responses to chronic suppression of central sympathetic outflow. Hypertension 60:749–756
Dampney RA, Coleman MJ, Fontes MA et al (2002) Central mechanisms underlying short- and long-term regulation of the cardiovascular system. Clin Exp Pharmacol Physiol 29:261–268
Lohmeier TE, Iliescu R (2015) The baroreflex as a long-term controller of arterial pressure. Physiology 30:148–158
Palatini P, Julius S (1997) Heart rate and cardiovascular risk. J Hypertens 15:3–17
Guzzetti S, Cogliati C, Turiel M et al (1988) Sympathetic predominance in essential hypertension: a study employing spectral analysis of heart rate variability. J Hypertens 6:711–717
Esler M, Lambert G, Jennings G (1989) Regional norepinephrine turnover in human hypertension. Clin Exp Hypertens 11:75–89
Anderson EA, Sinkey CA, Lawton WJ, Mark AL (1989) Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 14:177–183
Huggett RJ, Burns J, Mackintosh AF, Mary D (2004) Sympathetic neural activation in non diabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 44:847–852
Grassi G, Dell’Oro R, Quarti-Trevano F et al (2005) Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 48:1359–1365
Grassi G, Cattaneo BM, Seravalle G et al (1998) Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 31:68–72
Egan BM, Stevens-Fabry S (2015) Prehypertension-prevalence, health risks and management strategies. Nat Rev Cardiol 12:289–300
Hering D, Kara T, Kucharska W et al (2013) High-normal blood pressure is associated with increased resting sympathetic activity but normal responses to stress tests. Blood Press 22:183–187
Seravalle G, Lonati L, Buzzi S et al (2015) Sympathetic nerve traffic and baroreflex function in optimal, normal and high-normal blood pressure states. J Hypertens 33:1411–1417
Pal GK, Adithan C, Dutta TK et al (2011) Assessment of sympathovagal imbalance by spectral analysis of heart rate variability in prehypertensive and hypertensive patients in Indian population. Clin Exp Hypertens 33:478–483
Grassi G, Seravalle G, Bertinieri G et al (2000) Sympathetic and reflex alterations in systodiastolic and systolic hypertension of the elderly. J Hypertens 18:587–593
DiBona GF (2013) Sympathetic nervous system and hypertension. Hypertension 61:556–560
Smith PA, Graham LN, Mackintosh AF et al (2002) Sympathetic neural mechanisms in white-coat hypertension. J Am Coll Cardiol 40:126–132
Grassi G, Seravalle G, Trevano FQ et al (2007) Neurogenic abnormalities in masked hypertension. Hypertension 50:537–542
Grassi G, Seravalle G, Quarti-Trevano F et al (2008) Adrenergic metabolic and reflex abnormalities in reverse and extreme dipper hypertensives. Hypertension 52:925–931
Greenwood JP, Scott EM, Stoker JB, Mary DA (2001) Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive. J Am Coll Cardiol 38:1711–1717
Schlaich MP, Kaye DM, Lambert E et al (2003) Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 108:560–565
Grassi G, Seravalle G, Quarti-Trevano F et al (2009) Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction. Hypertension 53:205–209
Converse RL, Jacobsen TN, Toto RD et al (1992) Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327:1912–1918
Grassi G, Quarti-Trevano F, Seravalle G et al (2011) Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 57:846–851
Kielstein JT, Fliser D (2007) The past, present and future of ADMA in nephrology. Nephrol Ther 3:47–54
Grassi G, Seravalle G, Ghiadoni L et al (2011) Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease. Clin J Am Soc Nephrol 6:2620–2627
Mancia G, Grassi G, Borghi C (2015) Hyperuricemia, urate deposition and the association with hypertension. Curr Med Res Opin 31(suppl 2):15–19
Grassi G, Padmanabhan S, Menni C et al (2011) Association between ADRA1A gene and the metabolic syndrome: candidate genes and functional counterpart in the PAMELA population. J Hypertens 29:1121–1127
Masuo K, Katsuya T, Fu Y et al (2005) Beta-2-adreneoreceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in non-obese normotensive individuals. Am J Hypertens 18:1009–1014
Seravalle G, Piperno A, Mariani R et al (2016) Alterations in sympathetic nerve traffic in genetic hemochromatosis before and after iron depletion therapy: a microneurographic study. Eur Heart J 37:988–995
Pongratz G, Straub RH (2014) The sympathetic nervous response in inflammation. Arthritis Res Ther 16:504–526
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Seravalle, G., Brambilla, G., Pizzala, D.P., Grassi, G. (2018). Nervous System. In: Berbari, A., Mancia, G. (eds) Disorders of Blood Pressure Regulation. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-319-59918-2_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-59918-2_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59917-5
Online ISBN: 978-3-319-59918-2
eBook Packages: MedicineMedicine (R0)